Targeting Interleukin-1 beta to Suppress Sympathoexcitation in Hypothalamic Paraventricular Nucleus in Dahl Salt-Sensitive Hypertensive Rats

Cardiovasc Toxicol. 2016 Jul;16(3):298-306. doi: 10.1007/s12012-015-9338-7.

Abstract

Findings from our laboratory indicate that expressions of some proinflammatory cytokines such as tumor necrosis factor, interleukin-6 and oxidative stress responses are increased in the hypothalamic paraventricular nucleus (PVN) and contribute to the progression of salt-sensitive hypertension. In this study, we determined whether interleukin-1 beta (IL-1β) activation within the PVN contributes to sympathoexcitation during development of salt-dependent hypertension. Eight-week-old male Dahl salt-sensitive (S) rats received a high-salt diet (HS, 8 % NaCl) or a normal-salt diet (NS, 0.3 % NaCl) for 6 weeks, and all rats were treated with bilateral PVN injection of gevokizumab (IL-1β inhibitor, 1 μL of 10 μg) or vehicle once a week. The mean arterial pressure (MAP), heart rate (HR) and plasma norepinephrine (NE) were significantly increased in high-salt-fed rats. In addition, rats with high-salt diet had higher levels of NOX-2, NOX-4 [subunits of NAD (P) H oxidase], IL-1β, NLRP3 (NOD-like receptor family pyrin domain containing 3), Fra-LI (an indicator of chronic neuronal activation) and lower levels of IL-10 in the PVN than normal-diet rats. Bilateral PVN injection of gevokizumab decreased MAP, HR and NE, attenuated the levels of oxidative stress and restored the balance of cytokines. These findings suggest that IL-1β activation in the PVN plays a role in salt-sensitive hypertension.

Keywords: Hypothalamic paraventricular nucleus; Interleukin-1 beta; NLRP3; Oxidative stress; Salt-sensitive hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antihypertensive Agents / pharmacology*
  • Arterial Pressure / drug effects*
  • Disease Models, Animal
  • Heart Rate / drug effects
  • Hypertension / blood
  • Hypertension / physiopathology
  • Hypertension / prevention & control*
  • Interleukin-10 / metabolism
  • Interleukin-1beta / antagonists & inhibitors*
  • Interleukin-1beta / metabolism
  • Male
  • Membrane Glycoproteins / metabolism
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Norepinephrine / blood
  • Oxidative Stress / drug effects
  • Paraventricular Hypothalamic Nucleus / drug effects*
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Paraventricular Hypothalamic Nucleus / physiopathology
  • Rats, Inbred Dahl
  • Sodium Chloride, Dietary
  • Superoxides / metabolism
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiopathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antihypertensive Agents
  • IL1B protein, rat
  • Interleukin-1beta
  • Membrane Glycoproteins
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • Sodium Chloride, Dietary
  • Superoxides
  • Interleukin-10
  • Cybb protein, rat
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases
  • Nox4 protein, rat
  • gevokizumab
  • Norepinephrine